Involvement of WRN helicase in immortalization and tumorigenesis by the telomeric crisis pathway

Oncology Letters

Volumn 2, Issue 4, 2011, Pages 609-611

  Masanobu, Sugimoto ^a   Furuichi, Yasuhiro ^a   Ide, Toshinori ^b   Goto, Makoto ^c  

^a GeneCare Research Institute   (Japan)

^b EHIME PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

^c TOIN UNIVERSITY OF YOKOHAMA   (Japan)

Author keywords

Alternative lengthening of telomeres; Immortalization; Telomeric crisis; WRN helicase

Indexed keywords

HELICASE; TELOMERASE; UNCLASSIFIED DRUG; WRN HELICASE;

AUTOSOMAL RECESSIVE DISORDER; CARCINOGENESIS; CHROMOSOME; CONTROLLED STUDY; ENZYME ACTIVITY; EPSTEIN BARR VIRUS; GENE; HUMAN; LYMPHOBLASTOID CELL; MALIGNANT TRANSFORMATION; NONHUMAN; PREMATURE AGING; REVIEW; TELOMERE; VIRUS CELL INTERACTION; WERNER SYNDROME; WRN GENE;

EID: 79958068528     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.298     Document Type: Review

References (18)

1. Goto M and Miller RW (eds): From Premature Gray Hair to Helicase - Werner Syndrome: Implications for Aging and Cancer. Japan Scientific Societies Press & Karger, Tokyo, 2001.
2. Yu CE, Oshima J, Fu YH, et al: Positional cloning of the Werner's syndrome gene. Science 272: 258-262, 1996.
3. Goto M, Miller RW, Ishikawa Y and Sugano H: Excess of rare cancers in Werner syndrome (adult progeria). Cancer Epidemiol Biomarkers Prev 5: 239-246, 1996.
4. Harley CB, Kim NW, Prowse KR, et al: Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol 59: 307-315, 1994.
5. Bryan TM, Englezou A, Gupta J, Bacchetti S and Reddel RR: Telomere elongation in immortal human cells without detectable telomerase activity. Embo J 14: 4240-4248, 1995.
6. Bryan TM and Reddel RR: Telomere dynamics and telomerase activity in in vitro immortalised human cells. Eur J Cancer 33: 767-773, 1997.
7. Matsuo T, Shimose S, Kubo T, Fujimori J, Yasunaga Y and Ochi M: Telomeres and telomerase in sarcomas. Anticancer Res 29: 3833-3836, 2009.
8. Sugimoto M, Tahara H, Okubo M, et al: WRN gene and other genetic factors affecting immortalization of human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Genet Cytogenet 152: 95-100, 2004.
9. Futami K, Ishikawa Y, Goto M, Furuichi Y and Sugimoto M: Role of Werner syndrome gene product helicase in carcinogenesis and in resistance to genotoxins by cancer cells. Cancer Sci 99: 843-848, 2008.
10. Laud PR, Multani AS, Bailey SM, et al: Elevated telomere- telomere recombination in WRN-deficient, telomere dysfunctional cells promotes escape from senescence and engagement of the ALT pathway. Genes Dev 19: 2560-2570, 2005.
11. Ishikawa F: Telomere crisis, the driving force in cancer cell evolution. Biochem Biophys Res Commun 230: 1-6, 1997.
12. Shay JW and Wright WE: Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 26: 867-874, 2005.
13. Sugimoto M, Tahara H, Ide T and Furuichi Y: Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Res 64: 3361-3364, 2004.
14. Okubo M, Tsurukubo Y, Higaki T, et al: Clonal chromosomal aberrations accompanied by strong telomerase activity in immortalization of human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Genet Cytogenet 129: 30-34, 2001.
15. Wang H and Blackburn EH: De novo telomere addition by Tetrahymena telomerase in vitro. Embo J 16: 866-879, 1997.
16. Zhu J, Zhao Y and Wang S: Chromatin and epigenetic regulation of the telomerase reverse transcriptase gene. Protein and Cell 1: 22-32, 2010.
17. Yehezkel S, Rebibo-Sabbah A, Segev Y, et al: Reprogramming of telomeric regions during the generation of human induced pluripotent stem cells and subsequent differentiation into fibroblast-like derivatives. Epigenetics 6: 63-75, 2011.
18. Shimamoto A, Sugimoto M and Furuichi Y: Molecular biology of Werner syndrome. Int J Clin Oncol 9: 288-298, 2004.